IVF Financials: INVO Fertility Inc AI Analysis

Home

Stock

IVF

Financials

IVF Financial

INVO Fertility Inc

0%

$0

At close: Apr 02, 16:00:00 GMT-4

0%

$0

Post-market: Apr 02, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is IVF?

INVO Fertility Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Sarasota, Florida and currently employs 28 full-time employees. The company went IPO on 2008-11-11. INVO Fertility Inc., formerly NAYA Biosciences, Inc., is a healthcare services company focused on the fertility marketplace and expanding access to assisted reproductive technology (ART) care for patients in need. Its segments include Fertility Clinic Services, INVOcell Device, and Therapeutics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, in vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution to third party-owned and operated fertility clinics. The INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

IVF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	6	6	3	0	4	1
Revenue Growth (YoY)	0%	100%	--	-100%	300%	0%
Cost of Revenue	4	3	1	0	0	0
Gross Profit	2	2	1	0	4	0
Selling, General & Admin	10	9	7	10	9	6
Research & Development	0	0	0	0	0	0
Operating Expenses	11	10	7	11	9	6
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-26	-9	-8	-10	-6	-8
Income Tax Expense	0	0	0	0	0	0
Net Income	-29	-9	-8	-10	-6	-8
Net Income Growth	314%	13%	-20%	67%	-25%	300%
Shares Outstanding (Diluted)	0.43	0	0	0	0	0
Shares Change (YoY)	3,093%	-80%	157%	11%	90%	25%
EPS (Diluted)	-67.77	-8,735.01	-1,476.95	-5,185.71	-3,594.59	-8,789.47
EPS Growth	-88%	491%	-72%	44%	-59%	240%
Free Cash Flow	-7	-3	-5	-6	-6	-4
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	33.33%	33.33%	33.33%	0%	100%	0%
Operating Margin	-150%	-116.66%	-200%	0%	-125%	-500%
Profit Margin	-483.33%	-150%	-266.66%	0%	-150%	-800%
Free Cash Flow Margin	-116.66%	-50%	-166.66%	0%	-150%	-400%
EBITDA	-9	-7	-6	-10	-5	-5
EBITDA Margin	-150%	-116.66%	-200%	0%	-125%	-500%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-9	-7	-6	-10	-5	-5
EBIT Margin	-150%	-116.66%	-200%	0%	-125%	-500%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Follow-Up Questions

What are INVO Fertility Inc's key financial statements?



According to the latest financial statement (Form-10K), INVO Fertility Inc has a total asset of $46, Net loss of $-9

What are the key financial ratios for IVF?



INVO Fertility Inc's Current ratio is 1.76, has a Net margin is -150, sales per share of $5,454.54.

How is INVO Fertility Inc's revenue broken down by segment or geography?



INVO Fertility Inc largest revenue segment is Fertility Clinic Services, at a revenue of 6,450,431 in the most earnings release.For geography, United States is the primary market for INVO Fertility Inc, at a revenue of 6,532,000.

Is INVO Fertility Inc profitable?



no, according to the latest financial statements, INVO Fertility Inc has a net loss of $-9

Does INVO Fertility Inc have any liabilities?



yes, INVO Fertility Inc has liability of 26

How many outstanding shares for INVO Fertility Inc?



INVO Fertility Inc has a total outstanding shares of 0

INVO Fertility Inc (IVF) Financial

IVF Stock Price Chart